{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:06:31Z","timestamp":1795064791941,"version":"4.10.2"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Blood biomarkers that can be used for preclinical Alzheimer\u2019s disease (AD) diagnosis would enable trial enrollment at a time when the disease is potentially reversible. Here, we investigated plasma neuronal-derived extracellular vesicle (nEV) cargo in patients along the Alzheimer\u2019s continuum, focusing on cognitively normal controls (NCs) with high brain \u03b2-amyloid (A\u03b2) loads (A\u03b2+).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study was based on the Sino Longitudinal Study on Cognitive Decline project. We enrolled 246 participants, including 156 NCs, 45 amnestic mild cognitive impairment (aMCI) patients, and 45 AD dementia (ADD) patients. Brain A\u03b2 loads were determined using positron emission tomography. NCs were classified into 84 A\u03b2\u2212 NCs and 72 A\u03b2+ NCs. Baseline plasma nEVs were isolated by immunoprecipitation with an anti-CD171 antibody. After verification, their cargos, including A\u03b2, tau phosphorylated at threonine 181, and neurofilament light, were quantified using a single-molecule array. Concentrations of these cargos were compared among the groups, and their receiver operating characteristic (ROC) curves were constructed. A subset of participants underwent follow-up cognitive assessment and magnetic resonance imaging. The relationships of nEV cargo levels with amyloid deposition, longitudinal changes in cognition, and brain regional volume were explored using correlation analysis. Additionally, 458 subjects in the project had previously undergone plasma A\u03b2 quantification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Only nEV A\u03b2 was included in the subsequent analysis. We focused on A\u03b2<jats:sub>42<\/jats:sub> in the current study. After normalization of nEVs, the levels of A\u03b2<jats:sub>42<\/jats:sub> were found to increase gradually across the cognitive continuum, with the lowest in the A\u03b2\u2212 NC group, an increase in the A\u03b2+ NC group, a further increase in the aMCI group, and the highest in the ADD group, contributing to their diagnoses (A\u03b2\u2212 NCs vs. A\u03b2+ NCs, area under the ROC curve values of 0.663; vs. aMCI, 0.857; vs. ADD, 0.957). Furthermore, nEV A\u03b2<jats:sub>42<\/jats:sub> was significantly correlated with amyloid deposition, as well as longitudinal changes in cognition and entorhinal volume. There were no differences in plasma A\u03b2 levels among NCs, aMCI, and ADD individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest the potential use of plasma nEV A\u03b2<jats:sub>42<\/jats:sub> levels in diagnosing AD-induced cognitive impairment and A\u03b2+ NCs. This biomarker reflects cortical amyloid deposition and predicts cognitive decline and entorhinal atrophy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01010-x","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T13:04:40Z","timestamp":1652360680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["\u03b2-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer\u2019s disease and predicts cerebral amyloidosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Tao-Ran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Xia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ning","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0377-7424","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"2","key":"1010_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312\u201339.","journal-title":"Cell."},{"issue":"4","key":"1010_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1010_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/14712598.2019.1554646","volume":"19","author":"MF Bachmann","year":"2019","unstructured":"Bachmann MF, Jennings GT, Vogel M. A vaccine against Alzheimer\u2019s disease: anything left but faith. Expert Opin Biol Ther. 2019;19(1):73\u20138.","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"1010_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13195-019-0529-5","volume":"11","author":"J Cummings","year":"2019","unstructured":"Cummings J, Feldman HH, Scheltens P. The \u201crights\u201d of precision drug development for Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):76.","journal-title":"Alzheimers Res Ther"},{"key":"1010_CR5","doi-asserted-by":"publisher","first-page":"111175","DOI":"10.1016\/j.mad.2019.111175","volume":"184","author":"TR Li","year":"2019","unstructured":"Li TR, Wang XN, Sheng C, et al. Extracellular vesicles as an emerging tool for the early detection of Alzheimer\u2019s disease. Mech Ageing Dev. 2019;184:111175.","journal-title":"Mech Ageing Dev"},{"key":"1010_CR6","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977.","DOI":"10.1126\/science.aau6977"},{"issue":"3","key":"1010_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nantod.2015.04.004","volume":"10","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann G, Herrmann IK, Stevens MM. Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges. Nano Today. 2015;10(3):397\u2013409.","journal-title":"Nano Today"},{"issue":"2","key":"1010_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.14-262048","volume":"29","author":"D Kapogiannis","year":"2015","unstructured":"Kapogiannis D, Boxer A, Schwartz JB, et al. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease. FASEB J. 2015;29(2):589\u201396.","journal-title":"FASEB J"},{"issue":"6","key":"1010_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, et al. Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(6):600\u20137.e1.","journal-title":"Alzheimers Dement"},{"key":"1010_CR10","doi-asserted-by":"publisher","unstructured":"Li TR, Yang Q, Hu X, Han Y. Biomarkers and tools for predicting Alzheimer\u2019s disease in the preclinical stage. Curr Neuropharmacol. 2022;20(4):713\u2013937. https:\/\/doi.org\/10.2174\/1570159X19666210524153901.","DOI":"10.2174\/1570159X19666210524153901"},{"issue":"2","key":"1010_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1096\/fj.201700731R","volume":"32","author":"EJ Goetzl","year":"2018","unstructured":"Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer\u2019s disease. FASEB J. 2018;32(2):888\u201393.","journal-title":"FASEB J"},{"issue":"11","key":"1010_CR12","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jamaneurol.2019.2462","volume":"76","author":"D Kapogiannis","year":"2019","unstructured":"Kapogiannis D, Mustapic M, Shardell MD, et al. Association of extracellular vesicle biomarkers with Alzheimer disease in the Baltimore longitudinal study of aging. JAMA Neurol. 2019;76(11):1340\u201351.","journal-title":"JAMA Neurol"},{"issue":"8","key":"1010_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L, Qiu Q, Zhang H, et al. Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15(8):1071\u201380.","journal-title":"Alzheimers Dement"},{"key":"1010_CR14","doi-asserted-by":"publisher","unstructured":"Delgado-Peraza F, Nogueras-Ortiz CJ, Volpert O, Liu D, Goetzl EJ, Mattson MP, Greig NH, Eitan E, Kapogiannis D. Neuronal and astrocytic extracellular vesicle biomarkers in blood reflect brain pathology in mouse models of Alzheimer\u2019s disease. Cells. 2021;10(5):993. https:\/\/doi.org\/10.3390\/cells10050993.","DOI":"10.3390\/cells10050993"},{"issue":"7","key":"1010_CR15","doi-asserted-by":"publisher","first-page":"e028188","DOI":"10.1136\/bmjopen-2018-028188","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Wang X, Su L, Hu X, Han Y. Sino longitudinal study on cognitive decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline. BMJ Open. 2019;9(7):e028188.","journal-title":"BMJ Open"},{"key":"1010_CR16","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.nicl.2021.102900","volume":"33","author":"TR Li","year":"2021","unstructured":"Li TR, Dong QY, Jiang XY, et al. Exploring brain glucose metabolic patterns in cognitively normal adults at risk of Alzheimer\u2019s disease: a cross-validation study with Chinese and ADNI cohorts. Neuroimage Clin. 2021;33:102900.","journal-title":"Neuroimage Clin"},{"key":"1010_CR17","doi-asserted-by":"publisher","first-page":"605734","DOI":"10.3389\/fcell.2020.605734","volume":"8","author":"TR Li","year":"2020","unstructured":"Li TR, Wu Y, Jiang JJ, et al. Radiomics analysis of magnetic resonance imaging facilitates the identification of preclinical Alzheimer\u2019s disease: an exploratory study. Front Cell Dev Biol. 2020;8:605734.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"1010_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1010_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","volume":"42","author":"MW Bondi","year":"2014","unstructured":"Bondi MW, Edmonds EC, Jak AJ, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275\u201389.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1010_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1010_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-210376","volume":"83","author":"W Du","year":"2021","unstructured":"Du W, Ding C, Jiang J, Han Y. Women exhibit lower global left frontal cortex connectivity among cognitively unimpaired elderly individuals: a pilot study from SILCODE. J Alzheimers Dis. 2021;83(2):653\u201363.","journal-title":"J Alzheimers Dis"},{"issue":"1101","key":"1010_CR22","doi-asserted-by":"publisher","first-page":"20181020","DOI":"10.1259\/bjr.20181020","volume":"92","author":"D Fakhry-Darian","year":"2019","unstructured":"Fakhry-Darian D, Patel NH, Khan S, et al. Optimisation and usefulness of quantitative analysis of 18F-florbetapir PET. Br J Radiol. 2019;92(1101):20181020.","journal-title":"Br J Radiol"},{"issue":"1","key":"1010_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13195-021-00811-w","volume":"13","author":"QY Dong","year":"2021","unstructured":"Dong QY, Li TR, Jiang XY, Wang XN, Han Y, Jiang JH. Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population. Alzheimers Res Ther. 2021;13(1):74.","journal-title":"Alzheimers Res Ther"},{"key":"1010_CR24","doi-asserted-by":"publisher","unstructured":"Mayblyum DV, Becker JA, Jacobs HIL, Buckley RF, Schultz AP, Sepulcre J, Sanchez JS, Rubinstein ZB, Katz SR, Moody KA, Vannini P, Papp KV, Rentz DM, Price JC, Sperling RA, Johnson KA, Hanseeuw BJ. Comparing PET and MRI biomarkers predicting cognitive decline in preclinical Alzheimer disease. Neurology. 2021;96(24):e2933\u201343. https:\/\/doi.org\/10.1212\/WNL.0000000000012108. Epub ahead of print.","DOI":"10.1212\/WNL.0000000000012108"},{"issue":"1","key":"1010_CR25","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"key":"1010_CR26","doi-asserted-by":"publisher","first-page":"592024","DOI":"10.3389\/fnagi.2020.592024","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, Zhao M, Lin L, Han Y. Plasma \u03b2-amyloid levels associated with structural integrity based on diffusion tensor imaging in subjective cognitive decline: the SILCODE study. Front Aging Neurosci. 2020;12:592024.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1010_CR27","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.1038\/s41598-021-89004-x","volume":"11","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, Verberk I, Vanbrabant J, et al. Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer\u2019s disease. Sci Rep. 2021;11(1):9736.","journal-title":"Sci Rep"},{"issue":"10","key":"1010_CR28","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.neurobiolaging.2015.03.016","volume":"36","author":"S Kaffashian","year":"2015","unstructured":"Kaffashian S, Tzourio C, Soumar\u00e9 A, et al. Association of plasma \u03b2-amyloid with MRI markers of structural brain aging the 3-City Dijon study. Neurobiol Aging. 2015;36(10):2663\u201370.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1010_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422\u201333.","journal-title":"Lancet Neurol"},{"key":"1010_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fnins.2017.00278","volume":"11","author":"M Mustapic","year":"2017","unstructured":"Mustapic M, Eitan E, Werner JK Jr, et al. Plasma extracellular vesicles enriched for neuronal origin: a potential window into brain pathologic processes. Front Neurosci. 2017;11:278.","journal-title":"Front Neurosci"},{"issue":"5","key":"1010_CR31","first-page":"702","volume":"25","author":"L Pulliam","year":"2019","unstructured":"Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer\u2019s disease. J Neuro-Oncol. 2019;25(5):702\u20139.","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"1010_CR32","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi M, Kovac A, Korff A, et al. CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(11):1125\u201331.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1010_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-021-00460-5","volume":"16","author":"Y Xia","year":"2021","unstructured":"Xia Y, Prokop S, Giasson BI. \u201cDon\u2019t Phos over tau\u201d: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer\u2019s disease and other tauopathies. Mol Neurodegener. 2021;16(1):37.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1010_CR34","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-190714","volume":"73","author":"X Wang","year":"2020","unstructured":"Wang X, Sun Y, Li T, Cai Y, Han Y. Amyloid-\u03b2 as a blood biomarker for Alzheimer\u2019s disease: a review of recent literature. J Alzheimers Dis. 2020;73(3):819\u201332.","journal-title":"J Alzheimers Dis"},{"key":"1010_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","volume":"128","author":"Y Qu","year":"2021","unstructured":"Qu Y, Ma YH, Huang YY, et al. Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;128:479\u201386.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1010_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M Chen","year":"1995","unstructured":"Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun. 1995;213(1):96\u2013103.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1010_CR37","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1212\/WNL.0000000000009874","volume":"95","author":"AC Van Harten","year":"2020","unstructured":"Van Harten AC, Wiste HJ, Weigand SD, et al. CSF biomarkers in Olmsted County: evidence of 2 subclasses and associations with demographics. Neurology. 2020;95(3):e256\u201367.","journal-title":"Neurology."},{"issue":"3","key":"1010_CR38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimers Dement"},{"key":"1010_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dadm.2016.04.001","volume":"3","author":"CN Winston","year":"2016","unstructured":"Winston CN, Goetzl EJ, Akers JC, et al. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst). 2016;3:63\u201372.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1010_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40035-020-00210-5","volume":"9","author":"A Zhao","year":"2020","unstructured":"Zhao A, Li Y, Yan Y, et al. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer\u2019s dementia. Transl Neurodegener. 2020;9(1):30.","journal-title":"Transl Neurodegener"},{"issue":"8","key":"1010_CR41","doi-asserted-by":"publisher","first-page":"E968","DOI":"10.1073\/pnas.1521230113","volume":"113","author":"J Kowal","year":"2016","unstructured":"Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113(8):E968\u201377.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1010_CR42","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1212\/WNL.0000000000008838","volume":"94","author":"KR Thomas","year":"2020","unstructured":"Thomas KR, Bangen KJ, Weigand AJ, et al. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology. 2020;94(4):e397\u2013406.","journal-title":"Neurology."},{"issue":"3","key":"1010_CR43","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awx365","volume":"141","author":"M Albert","year":"2018","unstructured":"Albert M, Zhu Y, Moghekar A, et al. Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain. 2018;141(3):877\u201387.","journal-title":"Brain."},{"issue":"4","key":"1010_CR44","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3233\/JAD-201474","volume":"81","author":"KJ Bangen","year":"2021","unstructured":"Bangen KJ, Thomas KR, Sanchez DL, et al. Entorhinal perfusion predicts future memory decline, neurodegeneration, and white matter hyperintensity progression in older adults. J Alzheimers Dis. 2021;81(4):1711\u201325.","journal-title":"J Alzheimers Dis"},{"key":"1010_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fnagi.2020.00176","volume":"12","author":"S Leandrou","year":"2020","unstructured":"Leandrou S, Lamnisos D, Mamais I, Kyriacou PA, Pattichis CS. Alzheimer\u2019s disease and neuroimaging initiative. Assessment of Alzheimer\u2019s disease based on texture analysis of the entorhinal cortex. Front Aging Neurosci. 2020;12:176.","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"1010_CR46","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger T, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859\u201366.","journal-title":"Neurology."},{"issue":"2","key":"1010_CR47","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1523\/JNEUROSCI.2111-20.2020","volume":"41","author":"X Chen","year":"2021","unstructured":"Chen X, Cassady KE, Adams JN, Harrison TM, Baker SL, Jagust WJ. Regional tau effects on prospective cognitive change in cognitively normal older adults. J Neurosci. 2021;41(2):366\u201375.","journal-title":"J Neurosci"},{"issue":"29","key":"1010_CR48","doi-asserted-by":"publisher","first-page":"10402","DOI":"10.1523\/JNEUROSCI.0150-15.2015","volume":"35","author":"FL Besson","year":"2015","unstructured":"Besson FL, La Joie R, Doeuvre L, et al. Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer\u2019s disease. J Neurosci. 2015;35(29):10402\u201311.","journal-title":"J Neurosci"},{"issue":"23","key":"1010_CR49","doi-asserted-by":"publisher","first-page":"e3104","DOI":"10.1212\/WNL.0000000000010747","volume":"95","author":"J Luo","year":"2020","unstructured":"Luo J, Agboola F, Grant E, et al. Sequence of Alzheimer disease biomarker changes in cognitively normal adults: a cross-sectional study. Neurology. 2020;95(23):e3104\u201316.","journal-title":"Neurology."},{"issue":"2","key":"1010_CR50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/brain\/awz403","volume":"143","author":"M Teylan","year":"2020","unstructured":"Teylan M, Mock C, Gauthreaux K, et al. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. Brain. 2020;143(2):611\u201321.","journal-title":"Brain."},{"key":"1010_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.dadm.2016.09.002","volume":"6","author":"JE Baker","year":"2017","unstructured":"Baker JE, Lim YY, Pietrzak RH, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: a meta-analysis. Alzheimers Dement (Amst). 2017;6:108\u201321.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"1010_CR52","first-page":"434","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan A, Pannee J, Karikari TK, et al. Population-based blood screening for preclinical Alzheimer\u2019s disease in a British birth cohort at age 70. Brain. 2021;144(2):434\u201349.","journal-title":"Brain."},{"issue":"3","key":"1010_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JAD-190533","volume":"71","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee P, Elmi M, Goozee K, et al. Ultrasensitive detection of plasma amyloid-\u03b2 as a biomarker for cognitively normal elderly individuals at risk of Alzheimer\u2019s disease. J Alzheimers Dis. 2019;71(3):775\u201383.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1010_CR54","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, et al. Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol. 2021;78(11):1375\u201382.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1010_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000496099","volume":"9","author":"MJ Chiu","year":"2019","unstructured":"Chiu MJ, Lue LF, Sabbagh MN, Chen TF, Chen HH, Yang SY. Long-term storage effects on stability of A\u03b21-40, A\u03b21-42, and total tau proteins in human plasma samples measured with immunomagnetic reduction assays. Dement Geriatr Cogn Dis Extra. 2019;9(1):77\u201386.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"1010_CR56","doi-asserted-by":"publisher","unstructured":"Perluigi M, Picca A, Montanari E, Calvani R, Marini F, Matassa R, Tramutola A, Villani A, Familiari G, Domenico FD, Butterfield DA, Oh KJ, Marzetti E, Valentini D, Barone E. Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles. Alzheimers Dement. 2021. https:\/\/doi.org\/10.1002\/alz.12499.\u00a0Epub ahead of print.","DOI":"10.1002\/alz.12499"},{"key":"1010_CR57","doi-asserted-by":"publisher","first-page":"135914","DOI":"10.1016\/j.neulet.2021.135914","volume":"755","author":"BI Arioz","year":"2021","unstructured":"Arioz BI, Tufekci KU, Olcum M, et al. Proteome profiling of neuron-derived exosomes in Alzheimer\u2019s disease reveals hemoglobin as a potential biomarker. Neurosci Lett. 2021;755:135914.","journal-title":"Neurosci Lett"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01010-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T15:08:40Z","timestamp":1652368120000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01010-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1010"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01010-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"23 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Xuanwu Hospital of Capital Medical University and was carried out in accordance with the Declaration of Helsinki. We confirm that we have read the journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}